SimBioSys presentations at the Fall 2010 ACS meeting

August 26th, 2010

SimBioSys co-founders, Prof. Peter Johnson (UK) and Dr. Zsolt Zsoldos (Canada), along with our collaborator Dr. Sean Ekins (USA), delivered five talks at this past ACS meeting. They said that the meeting was a great opportunity to catch up with people they know and to meet new people. According to them, many of the other talks they attended were inspiring, and now, as they are making their journeys back home, their presentations are being posted here to share the science with you:

http://www.simbiosys.com/science/presentations/index.html

Peter Johnson et.al.: “Automated retrosynthetic analysis: An old flame rekindled”
view slides
http://www.simbiosys.com/science/presentations/2010-08-acs/ARChem_ACS_Boston_2010_final.pdf
Sean Ekins et.al.: “LASSO-ing potential pregnane X receptor agonists”
view slide
http://www.simbiosys.com/science/presentations/2010-08-acs/ACS2010_LASSO.pdf
Zsolt Zsoldos et.al: “How eHiTS solves the docking and scoring problems”
view slides
http://www.simbiosys.com/science/presentations/2010-08-acs/ACS2010_eHiTS_lessons.pdf
Zsolt Zsoldos et.al: “Scoring performance of eHiTS on the CSAR dataset”
view slides
http://www.simbiosys.com/science/presentations/2010-08-acs/ACS2010_CSAR_ehits_score.pdf
Zsolt Zsoldos et.al: “Protein-ligand docking on the Cell/BE processor with eHiTS Lightning”
view slides
http://www.simbiosys.com/science/presentations/2010-08-acs/ACS2010_HPC_ehits.pdf

posted by: Aniko

Meet up with SimBioSys at the Fall ACS Meeting in Boston in 10 days

August 11th, 2010

Only 10 days left to the upcoming ACS meeting in Boston (Sun Aug 21 - Thurs Aug 26), and most of the people attending are preparing their personal schedules: the must-go-lectures, the booths at the expo floor showing the latest and greatest technology, and the social networking and get-togethers.

SimBioSys will be there with no exception. We will be showcasing our latest product releases at booth: # 945. The focus will be on the new:
* ARChem 2010 release:
http://www.simbiosys.com/blog/2010/07/06/a-new-archem-release-integrable-more-efficient-and-better-performing/
* The upcoming CLiDE v 4.0 release that is currently in BETA testing - and shows significant improvement in recognition of chemical structures from PDF files and images.
* eHiTS, the exciting participant of the first CSAR benchmark exercise!

The science, algorithms and software design that are embodied in these products will be discussed in five different talks given by:

Zsolt Zsoldos:

COMP 25:
How eHiTS solves the docking and scoring problems
Session:Drug Discovery (08:30 AM - 11:45 AM)
Time: Sunday, August 22, 2010 09:30 AM
Location: Boston Convention & Exhibition Center
Room:Room 154

COMP 59
Protein-ligand docking on the Cell/BE processor with eHiTS Lightning
Session: Scripting & Programming
Time: Sunday, August 22, 2010 03:50 PM
Location: Boston Convention & Exhibition Center
Room: Room 157A

COMP 122
Scoring performance of eHiTS on the CSAR dataset
Session: The Community Structure-Activity Resource (CSAR) Scoring Challenge (09:00 AM - 11:50 AM)
Time: Monday, August 23, 2010 10:05 AM
Location: Boston Convention & Exhibition Center
Room: Room 157B

Peter Johnson:
CINF 42
Automated retrosynthetic analysis: An old flame rekindled
Session: The Journal of Chemical Information and Modeling’s 50th Anniversary Symposium
Time: Monday, August 23, 2010 - 11:40 AM
Location: Boston Convention & Exhibition Center
Room: Room 156A

Sean Ekins who has been collaborating with us in the past few months:
TOXI 4
LASSO-ing potential pregnane X receptor agonists
Session: General Papers
Time: Sunday, August 22, 2010 09:00 AM
Location:Boston Convention & Exhibition Center
Room: Room 252B

We hope you will find these talks interesting and that you will catch up with the SimBioSys researchers either following these presentations or at the booth. If you would like to schedule a meeting with us in advance please contact: aniko *at* simbiosys dot com

Have a great ACS meeting, and an enjoyable trip to Boston.
posted by Aniko

A new ARChem release: integrable, more efficient and better performing

July 6th, 2010

One of the aspects of maturation is the transition from the egocentric viewpoint to a phase where one engages and considers others. It is true for kids that begin to understand and cope with social situations. It is true for soccer players, or scientists for that matter, that understand that it is not all about personal skills and knowledge, but it is also about how you utilize those in the team play. And it is true for software applications that shift from the stage of proving their algorithms’ capabilities, to become integrable with other applications and merge into a workflow that creates real value for the user.

Since the previous release, work has continued on improving reaction rules generation in ARChem as well as the retrosynthetic search. Significant progress has been made in detecting and highlighting potential functional groups interference. The chemoselectivity issue is a challenge that requires a combination of data mining, profound chemical perception, and supplemental expert knowledge-bases. Another area that recorded a significant improvement is scoring. The retrosynthetic search commonly generates a vast solutions-space with hundreds, and possibly thousands of paths. Navigating systematically through all the options is typically too time consuming, and scoring becomes pivotal in prioritizing the solutions for the user to inspect. Scoring now better reflects a chemist’s assessment regarding the feasibility of a synthetic route. It accounts for synthetic depth, reliability of individual reaction steps, yield, wastage, chemical interference and other considerations in a successful balance.

Alongside the major improvements in the underlying technology, the focus of the last few months has been on usability and integrability:

  1. Reaction examples are directly linked to the Reaxys records for full data and literature access.

  2. Starting materials arrived at during the search are pointing to the corresponding records in online chemical vendors catalogues.

  3. Costs of starting materials are displayed, and route cost is evaluated.

  4. As a rule is being used in the analysis, the example reactions that were used to generate this rule are now ordered by relevance to the synthetic route.

  5. The solutions space can be pruned using user-defined filters.

  6. Changes to the GUI make solutions navigation more efficient, and the general look and feel of the system is more polished and refined.

Here is an example that demonstrates some of the features mentioned above, and also elegantly validates the concept of automated retrosynthetic chemistry. The suggested route was ranked number 1 by the system. It manifests a sequence of three reaction rules that simplify the target all the way to commercially available starting materials,  shown with their associated prices per mole. In this particular  case, all the suggested transforms were actually exactly found in the set of reactions that generated the respective rules during the automated process of retrosynthetic-rule extraction. All the examples, and the exact-matches can be accessed via the links provided along the retrosynthetic tree. At the bottom right we show a literature reference for a synthesis of the molecule validating the route.  ARChem offers a set of 28 distinct solutions that constitute a gateway to a much larger solutions space that can be accessed through the “n of m transforms” links. The user can build different solutions by selecting any of the suggested alternative transforms.

Paullone derivate, CDK inhibitor

ARChem has made a long way from its proof of concept days. It is now maturing into a tool that can offer real benefits to the medicinal or process chemist, not the least thanks to the continuous feedback that we get from users. In the next few months substantial changes are anticipated in all the aspects of the system. Maturity does not mean stagnation – ARChem is at the forefront of the field of computer aided synthesis design, and intensive R&D guarantees that major advances are still to come. Stay tuned.

posted by Orr

An interesting discussion on: The Ideal Synthesis

June 30th, 2010

We are dedicated readers of Derek Lowe’s wonderful blog about the  pharmaceutical industry and drug discovery. With his witty style, Lowe is covering many aspects of this field, and is shedding light on many facets that are not always very obvious for people like us who are not directly involved in drug discovery. It is no surprise that the blog has attracted a  sizable group of commentators that add their own experienced perspectives to the posts.

One of his latest entries discussed the concept of the “Ideal Synthesis”.  While largely an elusive notion, thinking about what constitutes a good synthesis, is an important discussion that we constantly hold between us and ARChem’s users. After all, typically ARChem generates a whole range of synthetic routes to target molecules, and while the user can browse through them all and choose the more useful routes in the specific scenario, the system does offer its own prioritization of solutions as a means of assistance to the user. The rank ordering of synthetic routes is trying to mimic a chemist’s  perspective, but this in itself, is not a well defined entity. Although we know what are the essential components, like: yield, minimal wastage, few synthetic steps, and robust reactions, striking the (or a) right balance between the terms is tricky. Lowe’s blog post, the paper it refers to, and the ensuing discussion there, are very helpful.

links:
http://pipeline.corante.com/archives/2010/06/29/the_ideal_synthesis.php
http://pubs.acs.org/doi/abs/10.1021/jo1006812

posted by Aniko

Induced Protonation State Changes Upon Binding

March 31st, 2010

There was an interesting article published recently in the Biophysical Journal, (Volume 98, Issue 5, 872-880, 3 March  2010, doi:10.1016/j.bpj.2009.11.016), in which biophysicists recognise the importance of protonation state induced changes upon binding - and mention that one of its key practical applications is in structure-based drug design.

Dr. Alexey Onufriev from Virginia Tech and his team investigated three types  (small molecule, protein and nucleic acid) of ligands and their ionization state changes upon protein-ligand binding. They concluded that in all tree cases substantial changes can be observed both in the ligand and also in the receptor ionization states upon binding.

This is a very important observation for virtual screening and docking, because this proves our belief that protonation states of the proteins and ligands can not and should not be prepared and / or fixed for virtual screening experiments. Therefore eHiTS’ method of assigning the protonation  states on-the-fly is probably the best method to-date offered to solve this problem. For more info on eHiTS’ automated protonation state handling, please see our technical note with the same title on this page: http://www.simbiosys.com/ehits/ehits_technical_notes.html

posted by Aniko

Presentations at the Fields Institute and at the Spring 2010 ACS meeting

March 8th, 2010

The Fields Institute, located in Toronto, is a center for mathematical research activity - a place where mathematicians from Canada and abroad, from business, industry and financial institutions, come together to carry out research and formulate problems of mutual interest.

SimBioSys founder and CSO, Zsolt Zsoldos, who is both a mathematician / computer scientist and a chemist, was recently invited to speak at one of the Fields’ Seminars. This was a great honour and recognition of the scientific
work he does at SimBioSys with his team of exceptional and talented researchers. The title of the March 2nd, 2010 presentation was: “Algorithmic and mathematical challenges in protein-ligand docking and scoring”, which has been a significant part of Zsolt’s work in the past 10 years. He tried squeezing it into just a 1 hour session, and that alone was a huge challenge. Nevertheless, there were many sparkling eyes in the audience, and hopefully the whole topic created enough interest so that we’ll see a few more mathematicians in this challenging field of science in the future. You can check out Zsolt’s talk at: http://www.simbiosys.com/science/presentations/index.html#2010
the audio and slides of the talk will be also shortly posted at Fields Institute’s web site at: http://www.fields.utoronto.ca/audio/#optimization_seminar

Another current, and interesting talk by a SimBioSys’ scientist will be given by Orr Ravitz at the upcoming spring 2010 ACS meeting in San Francisco. He will be talking about “Improving molecular docking through eHiTS’ tunable
scoring function”, in the Drug Discovery session on Monday March 22, 2010 at 10:00 am.

Abstract: The molecular docking paradigm has been hampered by the lack of a generically well performing scoring function. We present two complementary family-based approaches for score-tuning that improve docking performance  using experimental data. One technique treats the relative weights of the eHiTS energy terms as parameters that can be adjusted to improve score-RMSD correlations. The other technique is employing ligand-based similarity to rescale the docking score such that better enrichment factors are achieved in virtual screening. We discuss the algorithmic details of the methods, and demonstrate the effects of score tuning on a variety of targets, including CDK2, BACE1 and AChBP, as well as on common benchmarks. We observe an average improvement of 10% in the top-rank pose RMSD, and a similar improvement for docking success (top pose under 2 A). An average EF(1%) of 15 is achieved for the targets in the DUD set.
http://abstracts.acs.org/chem/239nm/program/view.php?obj_id=9832&terms=

Should be a discussion starter! Please join us for the session if you’ll be at the ACS meeting in SFO in two weeks, and contact us if you would like to meet  with us during the days of the conference.
posted by Aniko

CLiDE – making chemical information a lot more accessible

January 27th, 2010

<meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.2in">As scientists we all learn to cope with ever growing amounts of information, coming from various sources. Scientific information, as virtually all types of information, is predominantly delivered in electronic formats – journal articles, patents, e-books, wiki pages, blogs, etc. We need this information to be readily accessible, and searchable, we archive it on our personal PCs, and on our organization’s servers and knowledge bases. As chemists, we have wonderful visualization techniques that allow us to sift through incredible amount of data, and information, but exactly in this place, there is a strong disconnect between the availability of information and its accessibility. 2D images of molecules are so pivotal to the way we digest chemistry, and yet, as images they are not too prone to our data mining tools. It would be great if publishers of chemistry articles were to retain the original structures in their electronic documents and there is no doubt that this will happen some time in the future.  But, for now, we need a tool which can translate chemistry images into a connection table format which could allow integration of data from the literature into existing chemistry software.</p> <p align="justify" style="margin-bottom: 0.2in">CLiDE is an optical chemical structure recognition engine. It extracts connection tables of molecules from 2D images in various formats: PDF, postscript, JPEG, BMP, PNG, and TIFF. CLiDE has been around for some time now, but in the last two years it finally got the development boost it deserved, in order to make it a cool and useful instrument for every chemist’s toolkit.  It is now equipped with a sleek GUI that can be used to read .pdf as well as a  variety of image file formats.  Any time you come across a structure of interest,  simply select it, extract it, and save it, or send it to your favourite chemical editor (currently ChemDraw, ISISDraw and SymyxDraw are supported). We all know the feeling of  looking at a page full of structures that are  relevant to our work, and would like to  transfer them to another application such as an Excel spreadsheet or a docking program  but redrawing them using a graphic editor is tedious and prone to mistakes. CLiDE takes  away this hassle. It comes in three flavours that can either process a single image  at a time (standard), a whole document at a time (professional), or a full library of documents in one go (batch).</p> <p align="justify" style="margin-bottom: 0.2in">Below you’ll find a demo clip of the new CLiDE product, please contact us to obtain a password to watch it.</p> <p align="justify" style="margin-bottom: 0.2in"><a target="_blank" title="CLiDE clip" href="http://www.simbiosys.com/blog/2010-01-clide/CLiDE-blog.html" /></p> <p><a target="_blank" title="CLiDE clip" href="http://www.simbiosys.com/blog/2010-01-clide/CLiDE-blog.html"> </a></p> <div style="text-align: center"><a target="_blank" title="CLiDE clip" href="http://www.simbiosys.com/blog/2010-01-clide/CLiDE-blog.html"><img align="middle" title="CLiDE clip" alt="CLiDE clip" src="http://www.simbiosys.com/clide/movie_icon.jpeg" /><br /> </a></div> </div> <script src="http://feeds.feedburner.com/~s/SimbiosysBlog?i=http://www.simbiosys.com/blog/2010/01/27/clide-making-chemical-information-a-lot-more-accessible/" type="text/javascript" charset="utf-8"></script> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2010/01/27/clide-making-chemical-information-a-lot-more-accessible/#comments" title="Comment on CLiDE – making chemical information a lot more accessible">1 Comment »</a></p> </div> <div class="post" id="post-87"> <h2><a href="http://www.simbiosys.com/blog/2009/12/15/in-memoriam-peter-csizmadia/" rel="bookmark" title="Permanent Link to In Memoriam: Peter Csizmadia">In Memoriam: Peter Csizmadia</a></h2> <small>December 15th, 2009 <!-- by aniko --></small> <div class="entry"> <p>I just learnt about a terrible news, that deeply saddened me. Peter Csizmadia, one of the founders of ChemAxon, and the father of Marvin,<a title="Missing Peter Csizmadia" target="_blank" href="http://missingpetercsizmadia.blogspot.com/2009/12/missing-peter-csizmadia.html"> disappeared <span style="color: #38761d" /> on a mountain climbing expedition in China, in October 2009</a>. I learnt about Peter, a few months ago, when I saw his breath taking picture on one of the summits of the world with a ChemAxon memorabilia:<br /> <a title="ChemAxon on the top of the world" target="_blank" href="http://picasaweb.google.com/real.csizi/PeterCsizmadia#5409623424222466162">http://picasaweb.google.com/real.csizi/PeterCsizmadia#5409623424222466162</a></p> <p>Very brave, and very talented - I thought - when I read about his background at the time. Since I know his brother Csizi, the other founder of ChemAxon, and many other exceptionally talented people at ChemAxon, this did not come as a surprise to me. ChemAxon IS a great team of exceptionally talented and hard working people, conquering even the most difficult peaks.</p> <p>My sincere condolences to the family, the company, and to science. Loss of Peter is a great tragedy. However, his short life was not in vain, the fruits of his work, like Marvin, make his memory live forever.</p> <p>posted by Aniko </p> </div> <script src="http://feeds.feedburner.com/~s/SimbiosysBlog?i=http://www.simbiosys.com/blog/2009/12/15/in-memoriam-peter-csizmadia/" type="text/javascript" charset="utf-8"></script> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/general-discussion/" title="View all posts in General Discussion" rel="category tag">General Discussion</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a> | <a href="http://www.simbiosys.com/blog/2009/12/15/in-memoriam-peter-csizmadia/#comments" title="Comment on In Memoriam: Peter Csizmadia">1 Comment »</a></p> </div> <div class="post" id="post-86"> <h2><a href="http://www.simbiosys.com/blog/2009/12/10/archem-20091-is-released/" rel="bookmark" title="Permanent Link to ARChem 2009.1 is released">ARChem 2009.1 is released</a></h2> <small>December 10th, 2009 <!-- by aniko --></small> <div class="entry"> <p><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in">2009 has been a year of major progress for ARChem, and the system has hit a number of significant milestones that secured its leading position in the field. We wanted to share a few of our achievements, and to extend our gratitude to many users whose comments have made an impact on the system.</p> <ol> <li> <p align="justify" style="margin-bottom: 0.08in">Chemistry – Several changes to chemical perception algorithms have been implemented. They improve the way target molecules are being addressed, and the way reaction rules are being extracted and clustered from reaction databases. Those improvements have made a small set of manually coded reaction rules obsolete, and have enhanced the system’s capability to deal with some of the challenging aspects of organic synthesis such as chemical interference, stereochemistry and regioselectivity.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">Data – As a knowledge-based system, ARChem is highly dependent on the quality and quantity of reactions data encapsulated in commercial databases. We are therefore grateful and proud to have further tightened our relationships with two leaders of the chemical information publishing industry: Elsevier and Symyx. Both CrossFire Beilstein, and Cheminform databases have been fully integrated into the system. Covering a vast spectrum of chemical reactions and offering valuable supporting information through the system.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">Breaking up starting materials – The search down a branch of the retrosynthetic tree stops whenever a starting material from the educts database is found. Sometimes it is desirable to break such compounds to even simpler precursors, since they are expensive to purchase, not in stock, etc. The user can now exclude starting materials matching the target molecules, and find synthetic routes to those compounds.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">Viewing solutions – The ability to browse through the manifold of generated solutions has been dramatically improved by a synoptic view of reaction steps. The user can see a “preview” of the various solutions by inspecting the list of the next proposed precursors, and jump directly to the associated solutions.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">System design – ARChem is now a more complete system which can be used not only as a local installation, but also as an online service. A queueing system, security features, accelerated search times and many other features have upgraded the system performance, accessibility and usability.</p> </li> </ol> <p align="justify" style="margin-bottom: 0.08in">Below is an example for a synthetic route found by ARChem for Maraviroc – an HIV drug that was developed in Pfizer’s labs in Sandwich, UK, and got FDA approval in 2007. ARChem’s solution includes 9 reactions, with 6 steps in the two longest paths. In this case, the retrosynthetic analysis leads all the way back to commercially available starting materials, shown with their corresponding providers and catalog numbers. ARChem supplies a lot more information to complete the experimental details of the synthetic scheme, such as, reaction conditions, bibliographic references, and additional starting materials providers and catalog numbers.</p> <p align="justify" style="margin-bottom: 0.08in"><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg" /></p> <p><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"> </a><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"> </a><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"> </a></p> <div style="text-align: center"><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"><img alt="Maraviroc Sol#13 with ARChem 2009.1" title="Maraviroc Sol#13 with ARChem 2009.1" src="http://www.simbiosys.ca/blog/images/maraviroc_solution_13_thumb.jpg" /></a></div> <div style="text-align: center">Click on the image to see it full size</div> <p align="justify" style="margin-bottom: 0.08in">The above suggested synthetic route has been generated completely automatically with no user intervention. It is a strong demonstration of the huge potential of this concept, and of the accomplishments so far. We look forward to 2010 with plenty of items in the ARChem pipeline, and we are particularly eager to continue the dialogue with our industrial and academic users – a scientific exchange that guarantees that the development process maintains continuous, rigorous and coherent progress.</p> <p align="justify" style="margin-bottom: 0.08in">posted by Orr Ravitz</p> </div> <script src="http://feeds.feedburner.com/~s/SimbiosysBlog?i=http://www.simbiosys.com/blog/2009/12/10/archem-20091-is-released/" type="text/javascript" charset="utf-8"></script> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/science/" title="View all posts in Science" rel="category tag">Science</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2009/12/10/archem-20091-is-released/#respond" title="Comment on ARChem 2009.1 is released">No Comments »</a></p> </div> <div class="post" id="post-85"> <h2><a href="http://www.simbiosys.com/blog/2009/12/01/ehits-2009-as-a-blind-docking-tool/" rel="bookmark" title="Permanent Link to eHiTS 2009 as a Blind Docking Tool">eHiTS 2009 as a Blind Docking Tool</a></h2> <small>December 1st, 2009 <!-- by aniko --></small> <div class="entry"> <p><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">As the molecular docking paradigm solidifies its status as a significant tool for drug discovery, chemists explore additional applications of the methods in ways that sometime stretch the existing algorithms to their limits. Most docking programs, including eHiTS, have not been designed or optimized to perform blind docking. In structure based drug discovery, the user is typically expected to define, at some level of accuracy, the binding pocket in the target of interest. The binding site is determined either based on known binding modes of ligands as found in crystal structures of complexes, or based on an educated hypothesis. There are cases, however, in which assumptions about the possible locations of binding hot spots are difficult or should be avoided altogether. This is the case, for example, when the existence of secondary binding sites is suspected, or when one would like to screen active ligands and other compounds on a range of targets to estimate the possibility for drug side-effects, toxicity, and other types of biological activities.</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">The standard eHiTS usage requires a rough definition of the binding pocket. This is done through the clip file. This file should contain at least two sets of coordinates (or two spatial points) that are located in the designated binding pocket. eHiTS then draws a box around those points, expands it to some extent in all directions and places the search grid inside that box. Then, the box is “flooded” with a virtual fluid to detect all the cavities which will define the binding surface. This is a highly automated process, but it still relies on that user-defined clipping. Commonly the native ligand, amino acids from the binding pocket, or a few atoms from either are chosen as a clip file. If eHiTS is run with the -complex option, the native ligand is inferred as the clipping coordinates. However, eHiTS could be used without any clipping. In this case, the entire receptor will be considered for docking. The whole protein will be flooded, and sufficiently deep clefts will be searched on its surface. The final space in which docking will be performed is defined by the interconnected pockets found on the target. The search grid in such scenarios is typically large, and extensive sampling is required. Nevertheless, the computational efficiency of the eHiTS algorithm allows good sampling in reasonable timescales.</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">Several eHiTS users expressed specific interest in blind docking in recent months, and therefore we decided to evaluate eHiTS’ performance in this context. We used the set that was used in an earlier blind docking evaluation (</font><a target="_blank" title="Reference 1" href="http://autodock.scripps.edu/resources/science/hetenyi2006b.pdf"><font color="#000080"><u><font face="Liberation Serif, Times New Roman, serif">Hetenyi and van der Spoel, </font></u></font><font color="#000080"><u><font face="Liberation Serif, Times New Roman, serif"><strong>2006 [1]</strong></font></u></font></a><font face="Liberation Serif, Times New Roman, serif">). We focused on the 43 complexes used in the paper and have not attempted to use the apo structures. 3 codes (1B70, 1FIW and 1QIZ) were left out because of uncertainty regarding the exact structure used in the paper for docking. The default accuracy (3) was used throughout the study. The average blind docking time was 9 minutes per receptor for this set.</font></p> <p align="justify" style="margin-bottom: 0.08in"><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif"><strong>Results</strong></font><font face="Liberation Serif, Times New Roman, serif">:</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">77.5% of the cases gave at least one conformation under 2 </font><font face="Liberation Serif, Times New Roman, serif">Å in the top 10 poses. In the other cases, one accumulative docking round using poses from the first round as clip files produced successful binding modes in the top 5 poses. The top rank pose is in most cases in the correct binding pocket, offering a good starting point for pose refinement.</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">The table <a target="_blank" title="eHiTS 2009.1 blind docking results in table form" href="http://www.simbiosys.ca/blog/2009-11-30-blind_docking_blog_results_table.html">here</a> details the results for the specific codes. The Job# column describes whether the results were obtained with a single blind docking run, or with 2 cycles. The Rank# and RMSD columns indicate the rank of the first pose under 2 Å and its RMSD from the crystallographic conformation. The last two columns indicate the top-rank and closest poses RMSDs.</font></p> <p><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">The blind docking of phenol into insulin (1MPJ) is shown in Picture1 below. The crystallographic pose is shown in cyan, and sample poses are shown in “hot spots” detected during docking. Those poses can be used to clip the receptor in accumulative docking runs in which the sampling is finer, and the binding pockets are better modelled. It should be noted that this code generates an unusually big number (5) of hot spots. In most cases in the set we observed three, two and often one hot spot, manifesting the detection of the correct binding pocket.</font></p> <p><img align="middle" title="1MPJ" alt="1MPJ" src="http://www.simbiosys.ca/blog/images/2009-11-30-picture1.jpg" /></p> <p><em>Picture1: Phenol binding to Insulin.Several potential binding pockets are detected for this small ligand.</em></p> <p>1NGP (N1G9 FAB fragment) is a case where the majority of poses are generated far from the native ligand. Picture 2 below shows that most of the poses are located in the big cavity between chains L and H of the crystal structure. Several poses, however, reproduce the x-ray binding mode (in cyan) with close to 1 Å RMSD.</p> <p><img align="middle" alt="1NGP" title="1NGP" src="http://www.simbiosys.ca/blog/images/2009-11-30-picture2.jpg" /></p> <p><em>Picture2: 2-(4-hydroxy-3-nitrophenyl)acetic acid docked into N1G9 FAB fragment. The majority of poses are located in the big cavity between chains L and H.</em></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif"><strong>Conclusion</strong></font><font face="Liberation Serif, Times New Roman, serif"><strong>s:</strong></font></p> <p>The above results clearly demonstrate the viability of eHiTS as a blind docking tool. In all cases the correct binding pocket has been identified in the top 32 solutions, and in most cases good poses under 2 Å and even 1 Å were found at the top of the generated poses. The conformations may be further refined by clipping the receptor for subsequent runs, and by working at higher accuracies. As always in eHiTS, the jobs are extremely easy to setup with a simple command line, and with no required preparation for the receptor or the ligand. This, and the speed of the calculations make eHiTS a high throughput blind docking solution.</p> <p align="justify" style="margin-bottom: 0.08in"><meta http-equiv="CONTENT-TYPE" content="text/html; charset=utf-8" /><title /><meta name="GENERATOR" content="OpenOffice.org 2.4 (Unix)" /><font face="Liberation Serif, Times New Roman, serif"> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } H2 { margin-bottom: 0.08in } H2.western { font-family: "Liberation Sans", "Arial", sans-serif; font-size: 14pt; font-style: italic } H2.cjk { font-family: "DejaVu Sans"; font-size: 14pt; font-style: italic } H2.ctl { font-family: "DejaVu Sans"; font-size: 14pt; font-style: italic } --> </style></font></p> <h2 class="western"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif">Reference:</font></font></h2> <ol><font face="Liberation Serif, Times New Roman, serif"> <font face="Liberation Serif, Times New Roman, serif"> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif" /></font> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif" /></font></font></font> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif" /></font></font></font></font></font></font> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"></p> <li>Hetenyi, C. Van der Spoel, D.: ”Blind docking of drug-sized compounds to proteins with up to a thousand residues.”;<br /> 2006 Feb 20;580(5):1447-50. Epub 2006 Jan 31.</li> <li><a target="_blank" title="eHiTS 2009.1 blind docking results in table form" href="http://www.simbiosys.ca/blog/2009-11-30-blind_docking_blog_results_table.html">Blind docking results for eHiTS 2009.1</a>, using the test set of Hetenyi et.al.[1]</li> <p></font></font></font></font></font></font></font></ol> <p><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font></font></font></font></p> <p><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font></font></font></font></p> <p align="left" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font></font></font></font></p> <p><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif">by Orr Ravitz</font></font></font></font> </font> </font></font> </p> </div> <script src="http://feeds.feedburner.com/~s/SimbiosysBlog?i=http://www.simbiosys.com/blog/2009/12/01/ehits-2009-as-a-blind-docking-tool/" type="text/javascript" charset="utf-8"></script> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/science/" title="View all posts in Science" rel="category tag">Science</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a>, <a href="http://www.simbiosys.com/blog/category/science/tips-and-hints/" title="View all posts in tips and hints" rel="category tag">tips and hints</a> | <a href="http://www.simbiosys.com/blog/2009/12/01/ehits-2009-as-a-blind-docking-tool/#respond" title="Comment on eHiTS 2009 as a Blind Docking Tool">No Comments »</a></p> </div> <div class="navigation"> <div class="alignleft"><a href="http://www.simbiosys.com/blog/page/2/">« Previous Entries</a></div> <div class="alignright"></div> </div> </div> <div id="sidebar"> <ul> <li> <a href="http://www.simbiosys.com"><img src="images/SimBioSysLogo_name_long.gif" width="200" ></a> </li> <li> <form method="get" id="searchform" action="http://www.simbiosys.com/blog/"> <div><input type="text" value="" name="s" id="s" /> <input type="submit" id="searchsubmit" value="Search" /> </div> </form> </li> <li> <form style="border:1px solid #ccc;padding:3px;text-align:center;" action="http://www.feedburner.com/fb/a/emailverify" method="post" target="popupwindow" onsubmit="window.open('http://www.feedburner.com/fb/a/emailverifySubmit?feedId=1550225', 'popupwindow', 'scrollbars=yes,width=550,height=520');return true"><p>Enter your email address:</p><p><input type="text" style="width:140px" name="email"/></p><input type="hidden" value="http://feeds.feedburner.com/~e?ffid=1550225" name="url"/><input type="hidden" value="SimBioSys Blog" name="title"/><input type="hidden" name="loc" value="en_US"/><input type="submit" value="Subscribe" /><p>Delivered by <a href="http://www.feedburner.com" target="_blank">FeedBurner</a></p></form> </li> <!-- Author information is disabled per default. Uncomment and fill in your details if you want to use it. <li><h2>Author</h2> <p>A little something about you, the author. Nothing lengthy, just an overview.</p> </li> --> <li> </li> <li class="pagenav"><h2>Pages</h2><ul><li class="page_item"><a href="http://www.simbiosys.com/blog/about/" title="About SimBioSys">About SimBioSys</a></li> </ul></li> <li><h2>Archives</h2> <ul> <li><a href='http://www.simbiosys.com/blog/2010/08/' title='August 2010'>August 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/07/' title='July 2010'>July 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/06/' title='June 2010'>June 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/03/' title='March 2010'>March 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/01/' title='January 2010'>January 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2009/12/' title='December 2009'>December 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/11/' title='November 2009'>November 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/10/' title='October 2009'>October 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/07/' title='July 2009'>July 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/06/' title='June 2009'>June 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/05/' title='May 2009'>May 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/03/' title='March 2009'>March 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/02/' title='February 2009'>February 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/01/' title='January 2009'>January 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2008/12/' title='December 2008'>December 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/11/' title='November 2008'>November 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/10/' title='October 2008'>October 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/09/' title='September 2008'>September 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/08/' title='August 2008'>August 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/07/' title='July 2008'>July 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/06/' title='June 2008'>June 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/05/' title='May 2008'>May 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/04/' title='April 2008'>April 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/03/' title='March 2008'>March 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/02/' title='February 2008'>February 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/01/' title='January 2008'>January 2008</a></li> </ul> </li> <li><h2>Categories</h2> <ul> <li><a href="http://www.simbiosys.com/blog/category/general-discussion/" title="View all posts filed under General Discussion">General Discussion</a> (21) </li> <li><a href="http://www.simbiosys.com/blog/category/news/" title="View all posts filed under News">News</a> (53) </li> <li><a href="http://www.simbiosys.com/blog/category/science/" title="View all posts filed under Science">Science</a> (34) </li> <li><a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts filed under Software products">Software products</a> (32) </li> <li><a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts filed under Technology">Technology</a> (21) </li> <li><a href="http://www.simbiosys.com/blog/category/science/tips-and-hints/" title="Tells us tips and hints on how to best use eHiTS, and other SimBioSys tools, to maximize your ROI (return on invested time, money, energy etc.). It’s a must-read!">tips and hints</a> (5) </li> <li><a href="http://www.simbiosys.com/blog/category/uncategorized/" title="View all posts filed under Uncategorized">Uncategorized</a> (1) </li> </ul> </li> <li id="linkcat-1"><h2>Blogroll</h2> <ul> <li><a href="http://www.chemspider.com/blog/" rel="contact colleague">ChemSpider</a></li> <li><a href="http://www.sciencebase.com/science-blog/index.php">Science Blog</a></li> <li><a href="http://usefulchem.blogspot.com/">Useful Chemistry</a></li> </ul> </li> <li id="linkcat-2"><h2>Science Links</h2> <ul> <li><a href="http://www.redbrick.dcu.ie/~noel/linux4chemistry/">Linux4Chemistry</a></li> <li><a href="http://www.ccl.net/">Computational Chemistry List</a></li> </ul> </li> <li><h2>Meta</h2> <ul> <li><a href="http://www.simbiosys.com/blog/wp-login.php">Login</a></li> <li><a href="http://wordpress.org/" title="Powered by WordPress, state-of-the-art semantic personal publishing platform.">WordPress</a></li> </ul> </li> </ul> </div> <hr /> <div id="footer"> <!-- If you'd like to support WordPress, having the "powered by" link someone on your blog is the best way, it's our only promotion or advertising. --> <p> SimBioSys Blog is proudly powered by <a href="http://wordpress.org/">WordPress</a> <br /><a href="feed:http://www.simbiosys.com/blog/feed/">Entries (RSS)</a> and <a href="feed:http://www.simbiosys.com/blog/comments/feed/">Comments (RSS)</a>. <!-- 18 queries. 0.407 seconds. --> </p> </div> </div> <!-- Gorgeous design by Michael Heilemann - http://binarybonsai.com/kubrick/ --> </body> </html>